tiprankstipranks
Trending News
More News >
Entera Bio Ltd (ENTX)
NASDAQ:ENTX
US Market

Entera Bio (ENTX) Financial Statements

Compare
425 Followers

Entera Bio Financial Overview

Entera Bio's market cap is currently $74.75M. The company's EPS TTM is $-0.07; its P/E ratio is -6.66; Entera Bio is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 181.00K$ 0.00$ 134.00K$ 571.00K$ 365.00K
Gross Profit$ 9.00K$ -56.00K$ -31.00K$ 198.00K$ 65.00K
Operating Income$ -9.59M$ -8.94M$ -13.07M$ -12.22M$ -11.17M
EBITDA$ -9.54M$ -8.80M$ -12.87M$ -12.16M$ -11.11M
Net Income$ -9.54M$ -8.89M$ -13.07M$ -12.19M$ -11.22M
Balance Sheet
Cash & Short-Term Investments$ 8.66M$ 11.02M$ 12.31M$ 24.89M$ 8.59M
Total Assets$ 9.39M$ 11.77M$ 13.13M$ 25.99M$ 9.72M
Total Debt$ 272.00K$ 390.00K$ 91.00K$ 302.00K$ 432.00K
Net Debt$ -8.39M$ -10.63M$ -12.22M$ -24.59M$ -8.16M
Total Liabilities$ 1.31M$ 1.38M$ 1.37M$ 3.42M$ 2.21M
Stockholders' Equity$ 8.08M$ 10.39M$ 11.75M$ 22.57M$ 7.51M
Cash Flow
Free Cash Flow$ -6.82M$ -7.33M$ -12.55M$ -9.08M$ -10.61M
Operating Cash Flow$ -6.82M$ -7.31M$ -12.50M$ -9.06M$ -10.56M
Investing Cash Flow$ -3.00K$ -17.00K$ -102.00K$ -17.00K$ -53.00K
Financing Cash Flow$ 4.48M$ 6.04M$ 13.00K$ 25.38M$ 4.05M
Currency in USD

Entera Bio Earnings and Revenue History

Entera Bio Debt to Assets

Entera Bio Cash Flow

Entera Bio Forecast EPS vs Actual EPS